Key result
Prolonged indomethacin therapy during pregnancy resulted in ductal constriction in 6.5%, oligohydramnios in 7.3%, and composite neonatal morbidity in 29% of cases.
Why the study?
Does prolonged indomethacin treatment during pregnancy cause oligohydramnios, constriction of the ductus arteriosus, or composite neonatal morbidity in pregnant women?
Cohort (n=124)
Does prolonged indomethacin treatment during pregnancy cause oligohydramnios, constriction of the ductus arteriosus, or composite neonatal morbidity in pregnant women?
Prolonged indomethacin therapy during pregnancy is rarely associated with ductal constriction and oligohydramnios, and these outcomes do not appear to be dose- or duration-dependent.
Answers are grounded in this paper and cite their sources.
Supports fetal surveillance with prolonged indomethacin; leaves open causality and optimal use in prospective trials.
The purpose of this study was to describe the fetal and newborn safety profile of prolonged indomethacin treatment during pregnancy. A retrospective cohort of 124 pregnant women treated with indomethacin was used to assess the outcomes of oligohydramnios, constriction of the ductus arteriosus, and composite neonatal morbidity. Eight patients (6.5%) developed ductal constriction and nine patients (7.3%) developed oligohydramnios. Composite morbidity occurred in 36 neonates (29%). Ductal constriction, oligohydramnios, and composite morbidity were not associated with duration of therapy, gestational age at start or stop of therapy, time between dosing and delivery, or dose regimen. Prolonged indomethacin therapy rarely is associated with ductal constriction and oligohydramnios.
No takes yet. Share an insight, caveat, or question.
Savage et al. (2007) conducted a cohort in Pregnancy (n=124). Prolonged indomethacin therapy was evaluated on Oligohydramnios, constriction of the ductus arteriosus, and composite neonatal morbidity. Prolonged indomethacin therapy during pregnancy resulted in ductal constriction in 6.5%, oligohydramnios in 7.3%, and composite neonatal morbidity in 29% of cases.
Synapse has enriched 10 related papers. Consider them for comparative context: